Protagonist Therapeutics, Inc - Common Stock (PTGX)
CUSIP: 74366E102
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 62,457,444
- Total 13F shares
- 46,239,107
- Share change
- -1,779,223
- Total reported value
- $819,492,437
- Put/Call ratio
- 75%
- Price per share
- $17.72
- Number of holders
- 126
- Value change
- -$246,905,195
- Number of buys
- 78
- Number of sells
- 63
Quarterly Holders Quick Answers
What is CUSIP 74366E102?
CUSIP 74366E102 identifies PTGX - Protagonist Therapeutics, Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74366E102:
Top shareholders of PTGX - Protagonist Therapeutics, Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
11%
|
7,116,383
|
$319,383,000 | — | 30 Jun 2021 | |
| BVF INC/IL |
13F
|
Company |
6%
|
3,754,095
|
$168,484,000 | — | 30 Jun 2021 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
5.6%
|
3,507,390
|
$157,412,000 | — | 30 Jun 2021 | |
| Consonance Capital Management LP |
13F
|
Company |
5.5%
|
3,446,874
|
$154,696,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.9%
|
3,040,541
|
$136,459,000 | — | 30 Jun 2021 | |
| Johnson & Johnson Innovation - JJDC, Inc. |
13F
|
Company |
3.9%
|
2,449,183
|
$109,919,000 | — | 30 Jun 2021 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.7%
|
2,329,680
|
$104,556,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.7%
|
2,288,034
|
$102,686,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
2.3%
|
1,454,620
|
$65,283,000 | — | 30 Jun 2021 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2.2%
|
1,362,790
|
$61,162,000 | — | 30 Jun 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.8%
|
1,155,200
|
$51,845,000 | — | 30 Jun 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.6%
|
986,254
|
$44,263,000 | — | 30 Jun 2021 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.4%
|
845,199
|
$37,933,000 | — | 30 Jun 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.3%
|
821,722
|
$36,880,000 | — | 30 Jun 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.3%
|
791,016
|
$35,499,000 | — | 30 Jun 2021 | |
| Obermeyer Wealth Partners |
13F
|
Company |
1.2%
|
761,018
|
$34,154,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
713,838
|
$32,037,000 | — | 30 Jun 2021 | |
| Novo Holdings A/S |
13F
|
Company |
0.96%
|
600,010
|
$26,928,000 | — | 30 Jun 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.88%
|
550,045
|
$24,686,000 | — | 30 Jun 2021 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.86%
|
536,920
|
$24,097,000 | — | 30 Jun 2021 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.73%
|
455,276
|
$20,433,000 | — | 30 Jun 2021 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.72%
|
449,082
|
$20,155,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.71%
|
444,585
|
$19,953,000 | — | 30 Jun 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.69%
|
433,428
|
$19,453,000 | — | 30 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.65%
|
403,208
|
$18,096,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.63%
|
391,943
|
$17,590,000 | — | 30 Jun 2021 | |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. |
13F
|
Company |
0.62%
|
388,228
|
$17,424,000 | — | 30 Jun 2021 | |
| Tri Locum Partners LP |
13F
|
Company |
0.55%
|
341,650
|
$15,333,000 | — | 30 Jun 2021 | |
| Laurion Capital Management LP |
13F
|
Company |
0.54%
|
337,109
|
$15,130,000 | — | 30 Jun 2021 | |
| Opaleye Management Inc. |
13F
|
Company |
0.53%
|
330,222
|
$14,820,000 | — | 30 Jun 2021 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.49%
|
302,965
|
$13,597,000 | — | 30 Jun 2021 | |
| Altium Capital Management LLC |
13F
|
Company |
0.45%
|
282,445
|
$12,676,000 | — | 30 Jun 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.45%
|
281,378
|
$12,629,000 | — | 30 Jun 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.41%
|
256,075
|
$11,493,000 | — | 30 Jun 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.4%
|
248,235
|
$11,141,000 | — | 30 Jun 2021 | |
| Commodore Capital LP |
13F
|
Company |
0.34%
|
210,600
|
$9,452,000 | — | 30 Jun 2021 | |
| Pinz Capital Management, LP |
13F
|
Company |
0.31%
|
196,000
|
$8,796,000 | — | 30 Jun 2021 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.24%
|
152,000
|
$6,813,000 | — | 30 Jun 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.23%
|
146,330
|
$6,567,000 | — | 30 Jun 2021 | |
| Twin Lakes Capital Management, LLC |
13F
|
Company |
0.23%
|
143,440
|
$6,438,000 | — | 30 Jun 2021 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.22%
|
140,100
|
$6,288,000 | — | 30 Jun 2021 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.22%
|
138,608
|
$6,221,000 | — | 30 Jun 2021 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.22%
|
137,198
|
$6,157,000 | — | 30 Jun 2021 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.21%
|
130,000
|
$5,834,000 | — | 30 Jun 2021 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
0.19%
|
119,391
|
$5,358,000 | — | 30 Jun 2021 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.19%
|
119,203
|
$5,350,000 | — | 30 Jun 2021 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.17%
|
106,534
|
$4,781,000 | — | 30 Jun 2021 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.17%
|
103,850
|
$4,661,000 | — | 30 Jun 2021 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.16%
|
101,019
|
$4,534,000 | — | 30 Jun 2021 | |
| ISZO CAPITAL MANAGEMENT LP |
13F
|
Company |
0.15%
|
93,883
|
$4,213,000 | — | 30 Jun 2021 |
Institutional Holders of Protagonist Therapeutics, Inc - Common Stock (PTGX) as of Q3 2021
As of 30 Sep 2021,
Protagonist Therapeutics, Inc - Common Stock (PTGX) was held by
126 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,239,107 shares.
The largest 10 holders included
FMR LLC, Point72 Asset Management, L.P., BVF INC/IL, BlackRock Inc., JOHNSON & JOHNSON, FARALLON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, STATE STREET CORP, RTW INVESTMENTS, LP, and Artal Group S.A..
This page lists
126
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
136
Q3 2021 holders
126
Holder diff
-10
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.